Published reports [35, 37–39, 62] and a database [63] convincingly show that many types of cancer, including breast cancer, lung cancer, cervical cancer, ovarian cancer, pancreatic cancer [64], CRC [39], have significantly lower levels of FcRn, which promotes tumor growth by increasing HSA endocytosis and consumption. This evidence concerns the gene FCGRT and lung carcinoma.